EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 27.20
-0.20 (-0.73%)
May 27, 2026, 4:35 PM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 117.96 million as of May 27, 2026. Its market cap has increased by 32.66% in one year.
Market Cap
117.96M
Enterprise Value
106.88M
Revenue
51.56M
Ranking
n/a
PE Ratio
58.31
Stock Price
27.20
Market Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 117.96M, an increase of 5,088.34%. That is a compound annual growth rate of 18.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 117.96M | 2.96% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 216.52B |
| GSK plc | 76.85B |
| Haleon | 30.46B |
| Smith & Nephew | 9.72B |
| Tristel | 183.10M |
| Diaceutics | 127.83M |
| Faron Pharmaceuticals Oy | 89.78M |
| Bioventix | 88.82M |